Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | increases expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of DCAF12L2 mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | increases expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of DCAF12L2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DCAF12L2 mRNA | CTD | PMID:33387578 | aflatoxin B1 | decreases methylation | ISO | DCAF12L2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of DCAF12L2 gene | CTD | PMID:27153756 | antirheumatic drug | increases expression | ISO | DCAF12L2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of DCAF12L2 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | multiple interactions | ISO | Dcaf12l2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCAF12L2 mRNA | CTD | PMID:27858113 | benzo[a]pyrene | affects methylation | ISO | DCAF12L2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of DCAF12L2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | DCAF12L2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of DCAF12L2 exon | CTD | PMID:27901495 | benzo[b]fluoranthene | decreases expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in decreased expression of DCAF12L2 mRNA | CTD | PMID:26377693 | benzo[b]fluoranthene | multiple interactions | ISO | Dcaf12l2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCAF12L2 mRNA | CTD | PMID:27858113 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of DCAF12L2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of DCAF12L2 mRNA | CTD | PMID:32156529 | butanal | increases expression | ISO | DCAF12L2 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of DCAF12L2 mRNA | CTD | PMID:26079696 | carbon nanotube | decreases expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | ISO | Dcaf12l2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DCAF12L2 mRNA | CTD | PMID:20938992 | chrysene | multiple interactions | ISO | Dcaf12l2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCAF12L2 mRNA | CTD | PMID:27858113 | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of DCAF12L2 mRNA | CTD | PMID:26033743 | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of DCAF12L2 mRNA | CTD | PMID:26033743 | dorsomorphin | multiple interactions | ISO | DCAF12L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | epoxiconazole | increases expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of DCAF12L2 mRNA | CTD | PMID:35436446 | folic acid | multiple interactions | ISO | Dcaf12l2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DCAF12L2 mRNA | CTD | PMID:20938992 | folic acid | increases expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | Folic Acid results in increased expression of DCAF12L2 mRNA | CTD | PMID:25629700 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of DCAF12L2 mRNA | CTD | PMID:33387578 | graphene oxide | decreases expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | graphene oxide analog results in decreased expression of DCAF12L2 mRNA | CTD | PMID:33227293 | L-methionine | multiple interactions | ISO | Dcaf12l2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DCAF12L2 mRNA | CTD | PMID:20938992 | lipopolysaccharide | multiple interactions | ISO | DCAF12L2 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | mercury dichloride | multiple interactions | ISO | DCAF12L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF12L2 mRNA | CTD | PMID:27188386 | methotrexate | increases expression | ISO | DCAF12L2 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of DCAF12L2 mRNA | CTD | PMID:24449571 | panobinostat | multiple interactions | ISO | DCAF12L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCAF12L2 mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | ISO | DCAF12L2 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of DCAF12L2 mRNA | CTD | PMID:26272509 | paracetamol | affects expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of DCAF12L2 mRNA | CTD | PMID:17562736 | pirinixic acid | decreases expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of DCAF12L2 mRNA | CTD | PMID:23811191 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | DCAF12L2 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | DCAF12L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | tetraphene | decreases expression | ISO | Dcaf12l2 (Mus musculus) | 6480464 | benz(a)anthracene results in decreased expression of DCAF12L2 mRNA | CTD | PMID:26377693 | tetraphene | multiple interactions | ISO | Dcaf12l2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCAF12L2 mRNA | CTD | PMID:27858113 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of DCAF12L2 mRNA | CTD | PMID:33387578 | valproic acid | increases methylation | ISO | DCAF12L2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of DCAF12L2 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | DCAF12L2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of DCAF12L2 mRNA | CTD | PMID:23179753 and PMID:28001369 | |